Suchergebnisse - "Cardiovascular Diseases diagnosis"

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Quelle: Groenewegen, A, Zwartkruis, V W, Rienstra, M, Zuithoff, N P A, Hollander, M, Koffijberg, H, Oude Wolcherink, M, Cramer, M J, van der Schouw, Y T, Hoes, A W, Rutten, F H & de Boer, R A 2024, 'Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD) : a multicentre, pragmatic, cluster-randomised, controlled trial', The Lancet Public Health, vol. 9, no. 2, pp. e88-e99. https://doi.org/10.1016/S2468-2667(23)00269-4
    The Lancet Public Health

    Dateibeschreibung: application/pdf

  7. 7
  8. 8
  9. 9

    Quelle: Reinikainen, J, Kuulasmaa, K, Oskarsson, V, Amouyel, P, Biasch, K, Brenner, H, De Ponti, R, Donfrancesco, C, Drygas, W, Ferrieres, J, Grassi, G, Grimsgaard, S, Iacoviello, L, Jousilahti, P, Kårhus, L L, Kee, F, Linneberg, A, Luksiene, D, Mariño, J, Moitry, M, Palmieri, L, Peters, A, Piwonska, A, Quarti-Trevano, F, Salomaa, V, Sans, S, Schmidt, C O, Schöttker, B, Söderberg, S, Tamosiunas, A, Thorand, B, Tunstall-Pedoe, H, Vanuzzo, D, Veronesi, G, Woodward, M, Lekadir, K & Niiranen, T 2023, 'Regional and temporal differences in the associations between cardiovascular disease and its classic risk factors: An analysis of 49 cohorts from 11 European countries', European Journal of Preventive Cardiology. https://doi.org/10.1093/eurjpc/zwad359

    Dateibeschreibung: application/pdf

  10. 10
  11. 11
  12. 12

    Quelle: BMC Cardiovasc Disord
    BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-11 (2024)

  13. 13
  14. 14
  15. 15

    Quelle: Dahl, M, Lindholt, J, Søgaard, R, Refsgaard, J, Svenstrup, D, Moeslund, N J, Bredsgaard, M & Høgh, A 2023, 'Relevance of the Viborg Population Based Screening Programme (VISP) for Cardiovascular Conditions Among 67 Year Olds : Attendance Rate, Prevalence, and Proportion of Initiated Cardiovascular Medicines Stratified By Sex', European Journal of Vascular and Endovascular Surgery, vol. 66, no. 1, pp. 119-129. https://doi.org/10.1016/j.ejvs.2023.03.014

    Dateibeschreibung: application/pdf

  16. 16
  17. 17
  18. 18
  19. 19

    Quelle: Hart, H E, Kievits, O, Rutten, F H & Hollander, M H 2023, 'Evaluation of SGLT-2 inhibitor treatment in type 2 diabetes patients with very high cardiovascular risk', Primary care diabetes, vol. 17, no. 2, pp. 190-194. https://doi.org/10.1016/j.pcd.2023.02.001

    Dateibeschreibung: application/pdf

  20. 20

    Weitere Verfasser: Emil Hagström P. Gabriel Steg Michael Szarek et al.

    Quelle: Circulation
    Circulation, 146, 9, pp. 657-672
    Hagström, E, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Danchin, N, Diaz, R, Goodman, S G, Harrington, R A, Jukema, J W, Liberopoulos, E, Marx, N, McGinniss, J, Manvelian, G, Pordy, R, Scemama, M, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Investigators & Bøttcher, M 2022, 'Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab', Circulation, vol. 146, no. 9, pp. 657-672. https://doi.org/10.1161/CIRCULATIONAHA.121.057807
    Circulation, vol 146, iss 9
    Circulation : an official journal of the American Heart Association / ed.-in-chief Ephraim Donosco 146(9), 657-672 (2022). doi:10.1161/CIRCULATIONAHA.121.057807

    Dateibeschreibung: application/pdf